Michael Milken: High Yield Bonds, Career and Philanthropy (2018)

Investor Tips
An interview with a pioneer of high yield bonds and philanthropist, Michael Milken. In this interview, Michael discusses his early life and developing the high yield bond market at Drexel Burnham Lambert. Michael also talks about his philanthropic work and the American dream. ???? Books about Michael Milken are located at the bottom of the description❗

Like if you enjoyed
Subscribe for more:http://bit.ly/InvestorsArchive
Follow us on twitter:http://bit.ly/TwitterIA

Other great Stock Market Investor videos:⬇

Ray Dalio on Hedge funds, Success and Life/Work: http://bit.ly/RDVid1

Charlie Munger on Common sense and Investing:http://bit.ly/CMVid1

Video Segments:
0:00 Introduction
1:12 Giving pledge?
1:38 Met your wife in high school?
2:19 Grew up in L.A?
2:38 Were you a good student?
3:07 Why did you change from science?
4:36 Wharton?
4:46 High yield bonds?
6:29 New York?
7:33 Moving to L.A?
8:55 BREAK
9:25 California lifestyle?
9:57 Inventing high yield bonds?
12:36 Did you reject any successful companies?
13:36 Leaving Drexel?
15:25 Prostate cancer?
18:12 Financing health?
19:22 BREAK
19:37 Education?
20:41 Regrets?
21:55 What is the American dream?

Michael Milken Books ???????????? (affiliate link)
The Predator’s Ball: http://bit.ly/PredatorsBall
Den Of Thieves: http://bit.ly/DenOfThievesMM

Interview Date: 21st October, 2018
Event: David Rubenstein Show
Original Image Source:http://bit.ly/MMilkenPic

Investors Archive has videos of all the Investing/Business/Economic/Finance masters. Learn from their wisdom for free in one place.

For more check out the channel.

Remember to subscribe, share, comment and like!

No advertising.

#InvestorsArchive

Articles You May Like

The new class war: A wealth gap between millennials
Cannabis stocks surge as Biden administration moves to reclassify marijuana
Capture The New Tax Breaks On Home Improvements
FTC Ban On Noncompete Agreements May Undermine Your Estate Plan
Eli Lilly beats on quarterly profit, hikes full-year guidance on strong sales of Zepbound, Mounjaro

Leave a Reply

Your email address will not be published. Required fields are marked *